|
1
|
Battistini A: Interferon regulatory
factors in hematopoietic cell differentiation and immune
regulation. J Interferon Cytokine Res. 29:765–780. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barnes BJ, Moore PA and Pitha PM:
Virus-specific activation of a novel interferon regulatory factor,
IRF-5, results in the induction of distinct interferon α genes. J
Biol Chem. 276:23382–23390. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takaoka A, Tamura T and Taniguchi T:
Interferon regulatory factor family of transcription factors and
regulation of oncogenesis. Cancer Sci. 99:467–478. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yanai H, Chen H-M, Inuzuka T, Kondo S, Mak
TW, Takaoka A, Honda K and Taniguchi T: Role of IFN regulatory
factor 5 transcription factor in antiviral immunity and tumor
suppression. Proc Natl Acad Sci USA. 104:3402–3407. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tamura T, Yanai H, Savitsky D and
Taniguchi T: The IRF family transcription factors in immunity and
oncogenesis. Annu Rev Immunol. 26:535–584. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu G and Barnes BJ: IRF-5 is a mediator of
the death receptor-induced apoptotic signaling pathway. J Biol
Chem. 284:2767–2777. 2009. View Article : Google Scholar
|
|
7
|
Graham RR, Kozyrev SV, Baechler EC, Reddy
MVPL, Plenge RM, Bauer JW, Ortmann WA, Koeuth T, González Escribano
MF, et al; Argentine and Spanish Collaborative Groups. A common
haplotype of interferon regulatory factor 5 (IRF5) regulates
splicing and expression and is associated with increased risk of
systemic lupus erythematosus. Nat Genet. 38:550–555. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dawidowicz K, Allanore Y, Guedj M, Pierlot
C, Bombardieri S, Balsa A, Westhovens R, Barrera P, Alves H,
Teixeira VH, et al: ECRAF: The interferon regulatory factor 5 gene
confers susceptibility to rheumatoid arthritis and influences its
erosive phenotype. Ann Rheum Dis. 70:117–121. 2011. View Article : Google Scholar
|
|
9
|
Mori T, Anazawa Y, Iiizumi M, Fukuda S,
Nakamura Y and Arakawa H: Identification of the interferon
regulatory factor 5 gene (IRF-5) as a direct target for p53.
Oncogene. 21:2914–2918. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barnes BJ, Kellum MJ, Pinder KE, Frisancho
JA and Pitha PM: Interferon regulatory factor 5, a novel mediator
of cell cycle arrest and cell death. Cancer Res. 63:6424–6431.
2003.PubMed/NCBI
|
|
11
|
Shin SH, Kim B-H, Jang J-J, Suh KS and
Kang GH: Identification of novel methylation markers in
hepatocellular carcinoma using a methylation array. J Korean Med
Sci. 25:1152–1159. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamashita M, Toyota M, Suzuki H, Nojima M,
Yamamoto E, Kamimae S, Watanabe Y, Kai M, Akashi H, Maruyama R, et
al: DNA methylation of interferon regulatory factors in gastric
cancer and noncancerous gastric mucosae. Cancer Sci. 101:1708–1716.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Massimino M, Vigneri P, Fallica M, Fidilio
A, Aloisi A, Frasca F and Manzella L: IRF5 promotes the
proliferation of human thyroid cancer cells. Mol Cancer. 11:212012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kreher S, Bouhlel MA, Cauchy P, Lamprecht
B, Li S, Grau M, Hummel F, Köchert K, Anagnostopoulos I, Jöhrens K,
et al: Mapping of transcription factor motifs in active chromatin
identifies IRF5 as key regulator in classical Hodgkin lymphoma.
Proc Natl Acad Sci USA. 111:E4513–E4522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kannian P and Green PL: Human T
lymphotropic virus type 1 (HTLV-1): Molecular biology and
oncogenesis. Viruses. 2:2037–2077. 2010. View Article : Google Scholar
|
|
16
|
Hasunuma T, Sumida T and Nishioka K: Human
T cell leukemia virus type-I and rheumatoid arthritis. Int Rev
Immunol. 17:291–307. 1998. View Article : Google Scholar
|
|
17
|
Grassmann R, Aboud M and Jeang K-T:
Molecular mechanisms of cellular transformation by HTLV-1 Tax.
Oncogene. 24:5976–5985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Currer R, Van Duyne R, Jaworski E, Guendel
I, Sampey G, Das R, Narayanan A and Kashanchi F: HTLV tax: A
fascinating multifunctional co-regulator of viral and cellular
pathways. Front Microbiol. 3:4062012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ohsugi T: A transgenic mouse model of
human T cell leukemia virus type 1-associated diseases. Front
Microbiol. 4:492013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suzuki S, Zhou Y, Refaat A, Takasaki I,
Koizumi K, Yamaoka S, Tabuchi Y, Saiki I and Sakurai H: Human T
cell lymphotropic virus 1 manipulates interferon regulatory signals
by controlling the TAK1-IRF3 and IRF4 pathways. J Biol Chem.
285:4441–4446. 2010. View Article : Google Scholar :
|
|
21
|
Sharma S, Mamane Y, Grandvaux N, Bartlett
J, Petropoulos L, Lin R and Hiscott J: Activation and regulation of
interferon regulatory factor 4 in HTLV type 1-infected T
lymphocytes. AIDS Res Hum Retroviruses. 16:1613–1622. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsuboi K, Iida S, Inagaki H, Kato M,
Hayami Y, Hanamura I, Miura K, Harada S, Kikuchi M, Komatsu H, et
al: MUM1/IRF4 expression as a frequent event in mature lymphoid
malignancies. Leukemia. 14:449–456. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Imaizumi Y, Kohno T, Yamada Y, Ikeda S,
Tanaka Y, Tomonaga M and Matsuyama T: Possible involvement of
interferon regulatory factor 4 (IRF4) in a clinical subtype of
adult T-cell leukemia. Jpn J Cancer Res. 92:1284–1292. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ramos JC, Ruiz P Jr, Ratner L, Reis IM,
Brites C, Pedroso C, Byrne GE Jr, Toomey NL, Andela V, Harhaj EW,
et al: IRF-4 and c-Rel expression in antiviral-resistant adult
T-cell leukemia/lymphoma. Blood. 109:3060–3068. 2007.
|
|
25
|
Yamagata T, Nishida J, Tanaka S, Sakai R,
Mitani K, Yoshida M, Taniguchi T, Yazaki Y and Hirai H: A novel
interferon regulatory factor family transcription factor,
ICSAT/Pip/LSIRF, that negatively regulates the activity of
interferon-regulated genes. Mol Cell Biol. 16:1283–1294.
1996.PubMed/NCBI
|
|
26
|
Sharma S, Grandvaux N, Mamane Y, Genin P,
Azimi N, Waldmann T and Hiscott J: Regulation of IFN regulatory
factor 4 expression in human T cell leukemia virus-I-transformed T
cells. J Immunol. 169:3120–3130. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grumont RJ and Gerondakis S: Rel induces
interferon regulatory factor 4 (IRF-4) expression in lymphocytes:
Modulation of interferon-regulated gene expression by rel/nuclear
factor κB. J Exp Med. 191:1281–1292. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ohtani K, Nakamura M, Saito S, Nagata K,
Sugamura K and Hinuma Y: Electroporation: Application to human
lymphoid cell lines for stable introduction of a transactivator
gene of human T-cell leukemia virus type I. Nucleic Acids Res.
17:1589–1604. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshida T, Miyagawa E, Yamaguchi K,
Kobayashi S, Takahashi Y, Yamashita A, Miura H, Itoyama Y and
Yamamoto N: IL-2 independent transformation of a unique human T
cell line, TY8-3, and its subclones by HTLV-I and -II. Int J
Cancer. 91:99–108. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mancl ME, Hu G, Sangster-Guity N,
Olshalsky SL, Hoops K, Fitzgerald-Bocarsly P, Pitha PM, Pinder K
and Barnes BJ: Two discrete promoters regulate the alternatively
spliced human interferon regulatory factor-5 isoforms. Multiple
isoforms with distinct cell type-specific expression, localization,
regulation, and function. J Biol Chem. 280:21078–21090. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saikh KU, Lee JS, Kissner TL, Dyas B and
Ulrich RG: Toll-like receptor and cytokine expression patterns of
CD56+ T cells are similar to natural killer cells in
response to infection with Venezuelan equine encephalitis virus
replicons. J Infect Dis. 188:1562–1570. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iki S, Yokota S, Okabayashi T, Yokosawa N,
Nagata K and Fujii N: Serum-dependent expression of promyelocytic
leukemia protein suppresses propagation of influenza virus.
Virology. 343:106–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yokosawa N, Kubota T and Fujii N: Poor
induction of interferon-induced 2′,5′-oligoadenylate synthetase
(2–5 AS) in cells persistently infected with mumps virus is caused
by decrease of STAT-1α. Arch Virol. 143:1985–1992. 1998. View Article : Google Scholar
|
|
34
|
Brenner CA, Tam AW, Nelson PA, Engleman
EG, Suzuki N, Fry KE and Larrick JW: Message amplification
phenotyping (MAPPing): A technique to simultaneously measure
multiple mRNAs from small numbers of cells. Biotechniques.
7:1096–1103. 1989.PubMed/NCBI
|
|
35
|
Subrata LS, Lowes KN, Olynyk JK, Yeoh GCT,
Quail EA and Abraham LJ: Hepatic expression of the tumor necrosis
factor family member lymphotoxin-β is regulated by interleukin
(IL)-6 and IL-1β: Transcriptional control mechanisms in oval cells
and hepatoma cell lines. Liver Int. 25:633–646. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hieshima K, Nagakubo D, Nakayama T,
Shirakawa AK, Jin Z and Yoshie O: Tax-inducible production of CC
chemokine ligand 22 by human T cell leukemia virus type 1
(HTLV-1)-infected T cells promotes preferential transmission of
HTLV-1 to CCR4-expressing CD4+ T cells. J Immunol.
180:931–939. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mori N and Prager D: Transactivation of
the interleukin-1α promoter by human T-cell leukemia virus type I
and type II Tax proteins. Blood. 87:3410–3417. 1996.PubMed/NCBI
|
|
38
|
Ishikawa C, Kawakami H, Uchihara J-N,
Senba M and Mori N: CD69 overexpression by human T-cell leukemia
virus type 1 Tax transactivation. Biochim Biophys Acta.
1833:1542–1552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Suzuki K, Bose P, Leong-Quong RY, Fujita
DJ and Riabowol K: REAP: A two minute cell fractionation method.
BMC Res Notes. 3:2942010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tanaka Y, Yoshida A, Takayama Y, Tsujimoto
H, Tsujimoto A, Hayami M and Tozawa H: Heterogeneity of antigen
molecules recognized by anti-tax1 monoclonal antibody Lt-4 in cell
lines bearing human T cell leukemia virus type I and related
retro-viruses. Jpn J Cancer Res. 81:225–231. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Matsumoto K, Shibata H, Fujisawa J-I,
Inoue H, Hakura A, Tsukahara T and Fujii M: Human T-cell leukemia
virus type 1 Tax protein transforms rat fibroblasts via two
distinct pathways. J Virol. 71:4445–4451. 1997.PubMed/NCBI
|
|
42
|
Kimura R, Ishikawa C, Rokkaku T, Janknecht
R and Mori N: Phosphorylated c-Jun and Fra-1 induce matrix
metalloproteinase-1 and thereby regulate invasion activity of 143B
osteosarcoma cells. Biochim Biophys Acta. 1813:1543–1553. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Santos SB, Porto AF, Muniz AL, de Jesus
AR, Magalhães E, Melo A, Dutra WO, Gollob KJ and Carvalho EM:
Exacerbated inflammatory cellular immune response characteristics
of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic
carriers. BMC Infect Dis. 4:72004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tschachler E, Robert-Guroff M, Gallo RC
and Reitz MS Jr: Human T-lymphotropic virus I-infected T cells
constitutively express lymphotoxin in vitro. Blood. 73:194–201.
1989.PubMed/NCBI
|
|
45
|
Iwakura Y, Saijo S, Kioka Y,
Nakayama-Yamada J, Itagaki K, Tosu M, Asano M, Kanai Y and Kakimoto
K: Autoimmunity induction by human T cell leukemia virus type 1 in
transgenic mice that develop chronic inflammatory arthropathy
resembling rheumatoid arthritis in humans. J Immunol.
155:1588–1598. 1995.PubMed/NCBI
|
|
46
|
Baba M, Okamoto M, Hamasaki T, Horai S,
Wang X, Ito Y, Suda Y and Arima N: Highly enhanced expression of
CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and
adult T-cell leukemia cells. J Virol. 82:3843–3852. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bazzoni F and Beutler B: The tumor
necrosis factor ligand and receptor families. N Engl J Med.
334:1717–1725. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tsukasaki K, Miller CW, Kubota T, Takeuchi
S, Fujimoto T, Ikeda S, Tomonaga M and Koeffler HP: Tumor necrosis
factor α polymorphism associated with increased susceptibility to
development of adult T-cell leukemia/lymphoma in human
T-lymphotropic virus type 1 carriers. Cancer Res. 61:3770–3774.
2001.PubMed/NCBI
|
|
49
|
Seki N, Yamaguchi K, Yamada A, Kamizono S,
Sugita S, Taguchi C, Matsuoka M, Matsumoto H, Nishizaka S, Itoh K,
et al: Polymorphism of the 5′-flanking region of the tumor necrosis
factor (TNF)-α gene and susceptibility to human T-cell lymphotropic
virus type I (HTLV-I) uveitis. J Infect Dis. 180:880–883. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Watters KM, Dean J, Hasegawa H, Sawa H,
Hall W and Sheehy N: Cytokine and growth factor expression by
HTLV-1 Lck-tax transgenic cells in SCID mice. AIDS Res Hum
Retroviruses. 26:593–603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Albrecht H, Shakhov AN and Jongeneel CV:
trans activation of the tumor necrosis factor alpha promoter by the
human T-cell leukemia virus type I Tax1 protein. J
Virol. 66:6191–6193. 1992.PubMed/NCBI
|
|
52
|
Krausgruber T, Saliba D, Ryzhakov G,
Lanfrancotti A, Blazek K and Udalova IA: IRF5 is required for
late-phase TNF secretion by human dendritic cells. Blood.
115:4421–4430. 2010. View Article : Google Scholar : PubMed/NCBI
|
